SCHEMBL6513287

SCHEMBL6513287

O=C(Cc1ccccc1)NC1C(=O)N2C(C(=O)OC(c3ccccc3)c3ccccc3)=C(CCl)CS[C@@H]12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.58
▸ CTDSP1 Q9GZU7 2/20 0.58
▸ MAPK1 P28482 1/20 0.57
▸ ALDH1A1 P00352 6/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ MAPT P10636 4/20 0.55
▸ POLB P06746 1/20 0.55
▸ PKM P14618 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ DUSP3 P51452 1/20 0.55
▸ PTPN5 P54829 1/20 0.55
▸ PTPN11 Q06124 1/20 0.55
▸ PLCG1 P19174 1/20 0.52
▸ PTGS1 P23219 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.48
▸ HSD17B10 Q99714 4/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ HPGD P15428 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27277447 1.00 TDP1 (0.58) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL7522418 1.00 TDP1 (0.58) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL9699333 1.00 TDP1 (0.58) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL9699338 1.00 TDP1 (0.58) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL9099342 1.00 TDP1 (0.58) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL1132359 0.92 TDP1 (0.59) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL11015972 0.92 TDP1 (0.59) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL7804219 0.92 TDP1 (0.59) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL10579475 0.92 TDP1 (0.59) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1
SCHEMBL9642504 0.92 TDP1 (0.59) TDP1CTDSP1MAPK1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005100367-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF 3-(2-SUBSTITUTED VINYL) CEPHALOSPORINS RANBAXY LABORATORIES LIMITED (IN) 2005-10-27 — — WO disclosed
EP-0236231-B1 Novel cephem compounds MEIJI SEIKA KAISHA (JP) 1994-05-04 — — EP disclosed
US-5171854-A Antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1992-12-15 — — US disclosed
EP-0145906-B1 CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-03-11 — — EP disclosed
US-5073551-A Antibiotics SAGAMI CHEMICAL RESEARCH CENTER (JP) 1991-12-17 — — US disclosed
US-4918068-A ACTIVE AGAINST GRAM POSITIVE BACTERIA MEIJI SEIKA KAISHA, LTD. (JP) 1990-04-17 — — US disclosed
EP-0335390-A2 Novel cephalosporin compounds SAGAMI CHEMICAL RESEARCH CENTER (JP) 1989-10-04 — — EP disclosed
EP-0236231-A2 Novel cephem compounds MEIJI SEIKA KAISHA LTD. (JP) 1987-09-09 — — EP disclosed
US-4632918-A Novel β-lactam antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1986-12-30 — — US disclosed
US-4622318-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-11-11 — — US disclosed
EP-0145906-A2 Cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-06-26 — — EP disclosed
US-4354022-A Process for preparing 3-methylenecepham compounds or a salt thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-10-12 — — US disclosed
Send feedback